IRCT20220317054318N1RecruitingPhase 3
The effect of oral L-arginine consumption on uterine artery resistance in women with recurrent implant failure
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 72
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 41 years (—)
- Sex
- Female
Inclusion Criteria
- •Infertile women aged 18-41 years
- •Infertile IVF candidate women with a history of failure twice
- •Women with endometrium suitable for embryo transfer
- •Women with good quality embryos for transfer
- •Women who have passed 2 months or more since the last ICSI test and transfer.
- •Women who have the opportunity to attend the follow-up according to the plan and have informed consent
- •Women with a normal size and shape of the uterus that has been confirmed by ultrasound or hysteroscopy
Exclusion Criteria
- •Patients who use nitrite or organic nitrate at the same time
- •Women with chronic diseases such as: severe liver, kidney, or cardiovascular failure, patients with a history of stroke or myocardial infarction
- •Women smokers
- •Women with stage 3 and 4 endometriosis
- •Women with a known etiology of implant failure such as anatomical disorders (diagnosed by hysterosalpingography), hormonal disorders, immunological disorders, trophoblasts, antiphospholipid antibodies, mutation in factor V, pro-thrombin, crew disorders Musomes are excluded from the study
- •Patients with side effects of L-arginine
- •Canceling the treatment cycle for any reason
- •Unwillingness of the person to continue participating in the study
Investigators
Similar Trials
Not yet recruiting
Phase 3
Effect of L-arginine versus placebo on intrauterine growth of the fetus in primigravid womeIRCT20120215009014N419Hamedan University of Medical Sciences150
Recruiting
Phase 3
The effect of oral L-arginine supplementation on improvement of cardiovascular function and pulmonary artery pressure in patients with major and Intermedia beta-thalassemiaBetha thalasemia.Beta thalassemiaD56.1IRCT20210220050430N1Iran University of Medical Sciences88
Completed
Phase 3
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
Recruiting
Phase 1
Arginine effect on height growth of childreIRCT20230603058376N1Ardabil University of Medical Sciences76
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60